Charming Medical Limited (MCTA)

29.36USD +0.00% (+0.00)

Over 1M: +0.0%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

29.2 29.4 29.6
7 Aug 12 Aug 17 Aug 20 Aug 25 Aug 28 Aug 2 Sep

Financials Annual

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
FY24 — Free Cash Flow: 84.8K FY24 — Net Income: 777.8K FY25 — Free Cash Flow: 138.4K FY25 — Net Income: 1.2M FY26 — Free Cash Flow: -1.6M FY26 — Net Income: -22.6K -1.2M -600K 0 600K 1.2M
FY24 FY25 FY26
Gross Profit Free Cash Flow Net Income

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

3.2
Oper. margin -0.61%
OE margin -32.4%
Gross margin 99.3%
Profit margin -0.47%
ROA -0.23%
ROCE -0.53%
ROE -0.44%
Accruals 12.1%
FCF margin -32.4%
OCF margin -25.3%
OCF / EBIT —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.8
EV/Sales 97.4×
EV/OE -301.0×
FCF yield -0.33%
P/B 91.5×
P/C 78.7×
Div. yield —
EV/EBIT —
EV/GP —
Fwd P/E —
P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

7.2
RPO / sales 0.63×
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5
ND/EBITDA 0.012
Cash / Debt 32.4×
Debt / Eq 0.036×
Debt payback 0.0 yr
Cash runway 3.8 yr
Quick ratio 1.9×
F-score 1.1 pts
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.0
Sales/sh Y/Y -26.6%
EPS Y/Y -101.8%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS next Y —
Sales CAGR 4Y —
Sales Q/Q —

3 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.